Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Compassionate Use of Belantamab Mafodotin for Treatment of Patients with Relapsed/Refractory Multiple Myeloma Heavily Treated. Spanish Experience

Blood (2021) 138 (Supplement 1): 3775.

https://doi.org/10.1182/blood-2021-151267

Published: 2021

Journal Articles

A Phase 2 Study of Odronextamab (REGN1979), a CD20 x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Blood (2020) 136 (Supplement 1): 28–29.

https://doi.org/10.1182/blood-2020-136344

Published: 2020

Journal Articles

Usefulness of Eltrombopag in Secondary ITP Patients in Clinical Practice

Tomás José González-López, MD, María Teresa Alvarez-Roman, MD, Cristina Pascual, MD, Blanca Sánchez-González, MD, Fernando Fernández-Fuentes, MD, Gloria Pérez-Rus, MD, José Angel Hernández-Rivas, MD, Silvia Bernat, MD, Montserrat Cortés, MD, José María Bastida, MD, Violeta Martínez-Robles, MD, Angeles Fernández-Rodríguez, MD, Pavel Olivera, MD, Estefanía Bolaños, MD, Rafael Alonso, MD, Laura Entrena, MD, Marta Gómez-Nuñez, MD, Nuria Bermejo, MD, María Paz Martínez-Badas, María Jesús Peñarrubia, MD, Arancha Alonso, MD, Inmaculada Soto, MD, María Yera Cobo, MD, Alberto Casaus, MD, Isabel Caparrós, MD, María Perera, MD, Reyes Jiménez Bárcenas, MD, Cecilia Heras, MD, María Calbacho, MD, Maria Tenorio, MD, Armando Luaña, MD, Elsa Lopez-Ansoar, MD, Gerardo Hermida, MD, Javier García-Frade, MD, José Ramón González-Porras, MD, Miguel A. Sanz, MD PhD

Blood (2015) 126 (23): 2263.

https://doi.org/10.1182/blood.V126.23.2263.2263

Published: 2015

Journal Articles

High Correlation Clinical Responses to 1 st Line Acute Myeloid Leukemia Treatment with an Ex Vivo Native Environment Precision Medicine Test

Pau Montesinos, MD, Joan Ballesteros, David Martínez-Cuadrón, Joaquín Martínez-López, Josefina Serrano, Jaime Perez de Oteyza, Pascual Fernández, Gabriela Rodriguez-Macías, Mª Belén Vidriales, Pilar Herrera, MD PhD, Mar Tormo, MD PhD, Juan Bergua, Raimundo García, MD, Susana Vives, Mª Ángeles Fernández, Esperanza Lavilla, MD, Santiago Jimenez, Jose Antonio Pérez-Simón, Adriana Simiele, Ataulfo González, Bernardo J. González, Carmen Burgaleta, Juan Antonio López, Concepción Bethancourt, Guiomar Bautista, Arancha Alonso, Mercedes Colorado, Jordi Sierra, Begoña Navas, José Angel Hernández-Rivas, Juan Antonio Vera, Mª Lourdes Amador, Raúl Cordoba, MD, Adolfo de la Fuente, Fernando Ramos, MD PhD MPH, Carlos Javier Cerveró, Consolación Rayón, Olga Salamero, Edelmira Martí, Aurelio López, Teresa Olavé, Marta Gaspar, Julian Gorrochategui, José Luis Rojas, Cristina Gomez, Pilar Hernández, Alicia Robles, Ignacio Ortega, Jesús Villoria, Federico Moscardó, Iñaki Troconiz, Miguel A. Sanz, MD PhD

Blood (2015) 126 (23): 4837.

https://doi.org/10.1182/blood.V126.23.4837.4837

Published: 2015

Journal Articles

Use of Eltrombopag after Romiplostim in Primary ITP Patients

Tomás José González-López, Cristina Pascual, María Teresa Álvarez-Román, Fernando Fernández-Fuentes, Blanca Sánchez-González, Isabel Caparrós, Isidro Jarque, María Eva Mingot, José Angel Hernández-Rivas, Mónica Martín-Salces, Laura Solán, Paola Beneit, Reyes Jiménez, Silvia Bernat, Marcio M. Andrade, Montserrat Cortés, María José Cortti, Susana Pérez-Crespo, Marta Gómez-Núñez, Pavel E. Olivera, Gloria Pérez-Rus, Violeta Martínez-Robles, Rafael Alonso, Angeles Fernández-Rodríguez, María Carmen Arratibel, María Perera, Carmen Fernández-Miñano, Miguel Angel Fuertes-Palacio, Juan Andrés Vázquez-Paganini, Luis Miguel Juárez-Salcedo, Inés Valcarce, Francisco Javier Díaz-Gálvez, Adriana Sainz, Rosa Fisac, Carlos Aguilar, María Paz Martínez-Badas, María Jesús Peñarrubia, Javier García-Frade, Maria Calbacho, Carmen de Cos, Manuel González-Silva, Erika Coria, Arancha Alonso, Alberto Casaus, Armando Luaña, Pilar Galán, Cristina Fernández-Canal, José Ramón González-Porras

Blood (2014) 124 (21): 2790.

https://doi.org/10.1182/blood.V124.21.2790.2790

Published: 2014

Journal Articles

Successful Discontinuation of Eltrombopag after Complete Remission in Patients with Primary Immune Thrombocytopenia

Tomás José González-López, Cristina Pascual, María Teresa Álvarez-Román, Fernando Fernández-Fuertes, Blanca Sánchez-González, Isabel Caparrós, Isidro Jarque, María Eva Mingot, José Ángel Hernández-Rivas, Mónica Martín-Salces, Laura Solán, Paola Beneit, Reyes Jiménez, Silvia Bernat, Marcio M Andrade, MD, Montserrat Cortés, Maria José Cortti, Susana Pérez-Crespo, Marta Gómez-Núñez, Pavel E. Olivera, Gloria Pérez-Rus, Violeta Martínez-Robles, Rafael Alonso, Angeles Fernández-Rodríguez, María Carmen Arratibel, María Perera, Carmen Fernández-Miñano, Miguel Angel Fuertes-Palacio, Juan Andrés Vázquez-Paganini, Isabel Gutierrez-Jomarrón, Inés Valcarce, Erik de Cabo, Adriana Sainz, Rosa Fisac, Carlos Aguilar, María Paz Martínez-Badas, María Jesús Peñarrubia, Javier Garcia-Frade, María Calbacho, Carmen de Cos, Manuel González-Silva, Erika Coria, Arancha Alonso, Alberto Casaus, Armando Luaña, Pilar Galán, Cristina Fernández-Canal, José Ramón González-Porras

Blood (2014) 124 (21): 1465.

https://doi.org/10.1182/blood.V124.21.1465.1465

Published: 2014

Journal Articles

Pharmacological Profile Of Cytarabine and Idarubicin In Patient Samples (ex vivo) With Newly Diagnosed Acute Myeloid Leukemia Identifies Responders Vs Non Responders

Blood (2013) 122 (21): 3923.

https://doi.org/10.1182/blood.V122.21.3923.3923

Published: 2013

Journal Articles

Personalizing Therapies With Ex Vivo Pharmacological Responses May Uncover The Differences Between IDA-DNR-MIT Among European AML Protocols

Blood (2013) 122 (21): 1294.

https://doi.org/10.1182/blood.V122.21.1294.1294

Published: 2013

Journal Articles

Sustained Response After Short-Medium-Term Treatment With Eltrombopag In Patients With ITP

Tomás José González-López, MD PhD, José Ramón González-Porras, MD PhD, Maryam Arefi, MD PhD, Erik De Cabo, PhD, Blanca Sanchez Gonzalez, MD PhD, Arancha Alonso, MD PhD, Mónica Martin, MD PhD, Reyes Jimenez, MD PhD, Maria Calbacho, MD PhD, Abelardo Bárez, MD PhD, Jesus F San Miguel, MD, PhD

Blood (2013) 122 (21): 2323.

https://doi.org/10.1182/blood.V122.21.2323.2323

Published: 2013

Journal Articles

Population Pharmacological Profiles Of AML Treatments In Patient Samples By Automated Flow Cytometry; A Bridge To Individualized Medicine

Blood (2013) 122 (21): 1347.

https://doi.org/10.1182/blood.V122.21.1347.1347

Published: 2013

Journal Articles

Eltrombopag Treatment of Thrombocytopenia in Advanced Myelodysplastic Syndromes and Acute Myeloid Leukemia: Results of the 8-Week Open-Label Part of an Ongoing Study

Moshe Mittelman, MD, Sarit Assouline, Evangelos Briasoulis, Arancha Alonso, MD, Regina Garcia Delgado, MD, Peter O'Gorman, M.D., Hyeoung Joon Kim, MD, PhD, Sung-Soo Yoon, MD, PhD, Andrey Zaritskey, Catherine M. Flynn, MD, MRCP, FRCPath, Yoo-Hong Min, María Diez-Campelo, Alexandr Myasnikov, Frank Mannino, Yasser Mostafa Kamel, Conrad Messam, Nicole L. Stone, PhD, Geoffrey W. Chan, MD

Blood (2012) 120 (21): 3822.

https://doi.org/10.1182/blood.V120.21.3822.3822

Published: 2012

Journal Articles

Idiopathic Cytopenia of Undetermined Significance (ICUS): Impact of Flow Cytometry Immunophenotyping (FCI) in the Diagnosis of Myelodysplastic Syndrome (MDS) When Morphology Is Not Conclusive.

Patricia Font, MD, Dolores Subira, PhD, Javier Loscertales, MD, Eva Arranz, PhD, Arancha Alonso, MD, M. Angeles Perez-Saenz, PhD, Antonio Escudero, PhD, Jose Maria Fernandez-Rañada, PhD, Teresa Vallespi, PhD

Blood (2007) 110 (11): 2467.

https://doi.org/10.1182/blood.V110.11.2467.2467

Published: 2007

Journal Articles

Flow Cytometry Applications in the Diagnosis of Myelodysplastic Syndrome (MDS): Analysis of 45 Cases.

Patricia Font, MD, Dolores Subira, MD, PhD, Maria C. Martinez-Chamorro, MD, PhD, Susana Castañon, Juan Lopez-Pascual, MD, PhD, Arancha Alonso, MD, Maria A. Perez-Saenz, MD, PhD, Juan J. Gil-Fernandez, MD, PhD, Concepcion Alaez, MD, Antonio Escudero, MD, PhD, Jose F. Tomas, MD, PhD, Jose M. Fernandez-Rañada, MD, PhD

Blood (2004) 104 (11): 4724.

https://doi.org/10.1182/blood.V104.11.4724.4724

Published: 2004

NARROW

Compassionate Use of Belantamab Mafodotin for Treatment of Patients with Relapsed/Refractory Multiple Myeloma Heavily Treated. Spanish Experience

A Phase 2 Study of Odronextamab (REGN1979), a CD20 x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Usefulness of Eltrombopag in Secondary ITP Patients in Clinical Practice

High Correlation Clinical Responses to 1 st Line Acute Myeloid Leukemia Treatment with an Ex Vivo Native Environment Precision Medicine Test

Use of Eltrombopag after Romiplostim in Primary ITP Patients

Successful Discontinuation of Eltrombopag after Complete Remission in Patients with Primary Immune Thrombocytopenia

Pharmacological Profile Of Cytarabine and Idarubicin In Patient Samples (ex vivo) With Newly Diagnosed Acute Myeloid Leukemia Identifies Responders Vs Non Responders

Personalizing Therapies With Ex Vivo Pharmacological Responses May Uncover The Differences Between IDA-DNR-MIT Among European AML Protocols

Sustained Response After Short-Medium-Term Treatment With Eltrombopag In Patients With ITP

Population Pharmacological Profiles Of AML Treatments In Patient Samples By Automated Flow Cytometry; A Bridge To Individualized Medicine

Eltrombopag Treatment of Thrombocytopenia in Advanced Myelodysplastic Syndromes and Acute Myeloid Leukemia: Results of the 8-Week Open-Label Part of an Ongoing Study

Idiopathic Cytopenia of Undetermined Significance (ICUS): Impact of Flow Cytometry Immunophenotyping (FCI) in the Diagnosis of Myelodysplastic Syndrome (MDS) When Morphology Is Not Conclusive.

Flow Cytometry Applications in the Diagnosis of Myelodysplastic Syndrome (MDS): Analysis of 45 Cases.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only